Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-10-16

AUTHORS

P Martin, N Bleyzac, G Souillet, C Galambrun, Y Bertrand, P H Maire, R W Jelliffe, G Aulagner

ABSTRACT

Summary:The aim of this study was to identify the risk factors for acute graft-versus-host disease (aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated donor (UD). In all, 87 children consecutively underwent allogeneic bone marrow transplantation (BMT) from MSD (n=36), and UD (n=51). GVHD prophylaxis included CsA alone (n=33) or with MTX (n=51). ATG was added in UD-BMT and thalassemic recipients. CsA whole-blood concentrations were measured by EMIT and the dosing regimen was monitored by Bayesian pharmacokinetic modelling. Trough blood concentration (TBC) during the first 2 weeks post transplantation was lower in children who developed grade II–IV aGVHD than those developing no GVHD or only grade I (57±9 vs 94±8 ng/ml, P=0.007), whereas peak blood concentration and area under concentration curve vs time were similar in both groups. TBC <85 ng/ml and ‘use of MTX’ were associated with aGVHD in MSD-SCT (P=0.003 and 0.007, respectively) as well as in UD-SCT (P=0.006 and 0.003). Donor age ⩾8 years was significant only in MSD-BMT. Our results have shown the significant decisive role of pharmacological factors such as CSA TBC or use of MTX in the occurrence of GVHD in MSD as well as in UD paediatric BMT. More... »

PAGES

881-887

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239

DOI

http://dx.doi.org/10.1038/sj.bmt.1704239

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002246124

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/14561988


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Acute Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Area Under Curve", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bayes Theorem", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Marrow Transplantation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Child, Preschool", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclosporine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Monitoring", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Graft vs Host Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Histocompatibility", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Incidence", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Infant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Risk Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Tissue Donors", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Pharmacy, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Pharmacy, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martin", 
        "givenName": "P", 
        "id": "sg:person.01254462007.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254462007.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "ADCAPT, A Charial Hospital, Francheville, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pharmacy, Debrousse Hospital, Lyon, France", 
            "ADCAPT, A Charial Hospital, Francheville, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bleyzac", 
        "givenName": "N", 
        "id": "sg:person.01250741512.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Souillet", 
        "givenName": "G", 
        "id": "sg:person.0740146060.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740146060.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Galambrun", 
        "givenName": "C", 
        "id": "sg:person.0636145504.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636145504.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France", 
          "id": "http://www.grid.ac/institutes/grid.413959.3", 
          "name": [
            "Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bertrand", 
        "givenName": "Y", 
        "id": "sg:person.01077622701.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "ADCAPT, A Charial Hospital, Francheville, France", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "ADCAPT, A Charial Hospital, Francheville, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Maire", 
        "givenName": "P H", 
        "id": "sg:person.01034324775.43", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034324775.43"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA", 
          "id": "http://www.grid.ac/institutes/grid.42505.36", 
          "name": [
            "Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jelliffe", 
        "givenName": "R W", 
        "id": "sg:person.011710475215.90", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011710475215.90"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Faculty of Pharmacy, University H Poincar\u00e9, Nancy, France", 
          "id": "http://www.grid.ac/institutes/grid.29172.3f", 
          "name": [
            "Department of Pharmacy, Debrousse Hospital, Lyon, France", 
            "Faculty of Pharmacy, University H Poincar\u00e9, Nancy, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aulagner", 
        "givenName": "G", 
        "id": "sg:person.075614563.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.075614563.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.bmt.1702460", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035839342", 
          "https://doi.org/10.1038/sj.bmt.1702460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bmt.1702868", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024488164", 
          "https://doi.org/10.1038/sj.bmt.1702868"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-10-16", 
    "datePublishedReg": "2003-10-16", 
    "description": "Summary:The aim of this study was to identify the risk factors for acute graft-versus-host disease (aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated donor (UD). In all, 87 children consecutively underwent allogeneic bone marrow transplantation (BMT) from MSD (n=36), and UD (n=51). GVHD prophylaxis included CsA alone (n=33) or with MTX (n=51). ATG was added in UD-BMT and thalassemic recipients. CsA whole-blood concentrations were measured by EMIT and the dosing regimen was monitored by Bayesian pharmacokinetic modelling. Trough blood concentration (TBC) during the first 2 weeks post transplantation was lower in children who developed grade II\u2013IV aGVHD than those developing no GVHD or only grade I (57\u00b19 vs 94\u00b18\u2009ng/ml, P=0.007), whereas peak blood concentration and area under concentration curve vs time were similar in both groups. TBC <85\u2009ng/ml and \u2018use of MTX\u2019 were associated with aGVHD in MSD-SCT (P=0.003 and 0.007, respectively) as well as in UD-SCT (P=0.006 and 0.003). Donor age \u2a7e8 years was significant only in MSD-BMT. Our results have shown the significant decisive role of pharmacological factors such as CSA TBC or use of MTX in the occurrence of GVHD in MSD as well as in UD paediatric BMT.", 
    "genre": "article", 
    "id": "sg:pub.10.1038/sj.bmt.1704239", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1096890", 
        "issn": [
          "0268-3369", 
          "1476-5365"
        ], 
        "name": "Bone Marrow Transplantation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "9", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "32"
      }
    ], 
    "keywords": [
      "matched-sibling donor", 
      "trough blood concentrations", 
      "bone marrow transplantation", 
      "pediatric bone marrow transplantation", 
      "use of MTX", 
      "unrelated donors", 
      "acute graft", 
      "host disease", 
      "marrow transplantation", 
      "risk factors", 
      "blood concentrations", 
      "CsA trough blood concentrations", 
      "allogeneic bone marrow transplantation", 
      "only grade I", 
      "occurrence of GVHD", 
      "pharmacological risk factors", 
      "peak blood concentration", 
      "weeks post transplantation", 
      "whole blood concentrations", 
      "GVHD prophylaxis", 
      "UD-BMT", 
      "MSD-SCT", 
      "UD-SCT", 
      "MSD-BMT", 
      "post transplantation", 
      "grade II", 
      "grade I", 
      "donor age", 
      "pharmacological factors", 
      "pharmacokinetic modelling", 
      "transplantation", 
      "MTX", 
      "aGVHD", 
      "GVHD", 
      "graft", 
      "disease", 
      "children", 
      "concentration curve", 
      "donors", 
      "prophylaxis", 
      "regimen", 
      "factors", 
      "recipients", 
      "CsA", 
      "age", 
      "concentration", 
      "group", 
      "aim", 
      "years", 
      "use", 
      "study", 
      "role", 
      "ATG", 
      "occurrence", 
      "time", 
      "curves", 
      "decisive role", 
      "area", 
      "results", 
      "emits", 
      "modelling"
    ], 
    "name": "Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors", 
    "pagination": "881-887", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002246124"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/sj.bmt.1704239"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "14561988"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/sj.bmt.1704239", 
      "https://app.dimensions.ai/details/publication/pub.1002246124"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_371.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1038/sj.bmt.1704239"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704239'


 

This table displays all metadata directly associated to this object as RDF triples.

268 TRIPLES      21 PREDICATES      107 URIs      97 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/sj.bmt.1704239 schema:about N016df5106e9142e5ac2dc1eb608b1b11
2 N03fc4492705b411bb9b9b017bbd75cee
3 N05d3562bae4941d6bfe0f68feb0077d5
4 N067883752ed649149d9f59d130179811
5 N1f476a9102724c6c80606458de758a9b
6 N289dc4e98f3b4805a50d4cdff5b77b01
7 N29979d378c9844468d3e0e2643c7ea34
8 N2a415ae37ce84586a4c3bf9738b1d1dd
9 N533b69c711d84a478f6f473456c86b05
10 N78921f08cf9f40d2a8bcf4e16bfcb64a
11 N79d20b3ce19d498d837beb153926c2c5
12 N8093d0521b9c42a994d01fbe468359a8
13 N997860bff4744eac9243d2e2627fb9d0
14 Nbdfdcd7db68740b8affe7c4cb3a36292
15 Nda8fbf829b5e41adbf2bb41b9f8b4eae
16 Ne540f593e86f4001830125e7187ce459
17 Ne69c0d2443e74e1683616aad41fe288d
18 Nf14858ad36034db6a72d8ce6a6b63cf8
19 Nf5349a43c6984f14b0ae8025b38e421a
20 anzsrc-for:11
21 anzsrc-for:1102
22 schema:author N6a08508279d444b69a54eadfcf76d33c
23 schema:citation sg:pub.10.1038/sj.bmt.1702460
24 sg:pub.10.1038/sj.bmt.1702868
25 schema:datePublished 2003-10-16
26 schema:datePublishedReg 2003-10-16
27 schema:description Summary:The aim of this study was to identify the risk factors for acute graft-versus-host disease (aGVHD) in children transplanted from a matched-sibling donor (MSD) or an unrelated donor (UD). In all, 87 children consecutively underwent allogeneic bone marrow transplantation (BMT) from MSD (n=36), and UD (n=51). GVHD prophylaxis included CsA alone (n=33) or with MTX (n=51). ATG was added in UD-BMT and thalassemic recipients. CsA whole-blood concentrations were measured by EMIT and the dosing regimen was monitored by Bayesian pharmacokinetic modelling. Trough blood concentration (TBC) during the first 2 weeks post transplantation was lower in children who developed grade II–IV aGVHD than those developing no GVHD or only grade I (57±9 vs 94±8 ng/ml, P=0.007), whereas peak blood concentration and area under concentration curve vs time were similar in both groups. TBC <85 ng/ml and ‘use of MTX’ were associated with aGVHD in MSD-SCT (P=0.003 and 0.007, respectively) as well as in UD-SCT (P=0.006 and 0.003). Donor age ⩾8 years was significant only in MSD-BMT. Our results have shown the significant decisive role of pharmacological factors such as CSA TBC or use of MTX in the occurrence of GVHD in MSD as well as in UD paediatric BMT.
28 schema:genre article
29 schema:isAccessibleForFree false
30 schema:isPartOf Nb3fc94d5ad134e378d3f09df4ac7bac3
31 Ne62e98ea7e0b437287b0ba09993e5031
32 sg:journal.1096890
33 schema:keywords ATG
34 CsA
35 CsA trough blood concentrations
36 GVHD
37 GVHD prophylaxis
38 MSD-BMT
39 MSD-SCT
40 MTX
41 UD-BMT
42 UD-SCT
43 aGVHD
44 acute graft
45 age
46 aim
47 allogeneic bone marrow transplantation
48 area
49 blood concentrations
50 bone marrow transplantation
51 children
52 concentration
53 concentration curve
54 curves
55 decisive role
56 disease
57 donor age
58 donors
59 emits
60 factors
61 grade I
62 grade II
63 graft
64 group
65 host disease
66 marrow transplantation
67 matched-sibling donor
68 modelling
69 occurrence
70 occurrence of GVHD
71 only grade I
72 peak blood concentration
73 pediatric bone marrow transplantation
74 pharmacokinetic modelling
75 pharmacological factors
76 pharmacological risk factors
77 post transplantation
78 prophylaxis
79 recipients
80 regimen
81 results
82 risk factors
83 role
84 study
85 time
86 transplantation
87 trough blood concentrations
88 unrelated donors
89 use
90 use of MTX
91 weeks post transplantation
92 whole blood concentrations
93 years
94 schema:name Clinical and pharmacological risk factors for acute graft-versus-host disease after paediatric bone marrow transplantation from matched-sibling or unrelated donors
95 schema:pagination 881-887
96 schema:productId N89e952a976234fe6b0055b29e8c7b1e9
97 Na5362ab379e449858e67333e417d2146
98 Na7ecd823fb86416e8587569fd2689682
99 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002246124
100 https://doi.org/10.1038/sj.bmt.1704239
101 schema:sdDatePublished 2022-12-01T06:23
102 schema:sdLicense https://scigraph.springernature.com/explorer/license/
103 schema:sdPublisher Nc7b034bfa431418f859e96fe68104be7
104 schema:url https://doi.org/10.1038/sj.bmt.1704239
105 sgo:license sg:explorer/license/
106 sgo:sdDataset articles
107 rdf:type schema:ScholarlyArticle
108 N016df5106e9142e5ac2dc1eb608b1b11 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Child, Preschool
110 rdf:type schema:DefinedTerm
111 N03fc4492705b411bb9b9b017bbd75cee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Tissue Donors
113 rdf:type schema:DefinedTerm
114 N05d3562bae4941d6bfe0f68feb0077d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Infant
116 rdf:type schema:DefinedTerm
117 N067883752ed649149d9f59d130179811 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Methotrexate
119 rdf:type schema:DefinedTerm
120 N0e625af632664671b86d252b1b5afeb7 rdf:first sg:person.01077622701.25
121 rdf:rest Nc23b545d4784466d89e26ec70e0116f6
122 N1f476a9102724c6c80606458de758a9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Humans
124 rdf:type schema:DefinedTerm
125 N289dc4e98f3b4805a50d4cdff5b77b01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Adolescent
127 rdf:type schema:DefinedTerm
128 N29979d378c9844468d3e0e2643c7ea34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Female
130 rdf:type schema:DefinedTerm
131 N2a415ae37ce84586a4c3bf9738b1d1dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Child
133 rdf:type schema:DefinedTerm
134 N533b69c711d84a478f6f473456c86b05 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Bayes Theorem
136 rdf:type schema:DefinedTerm
137 N5368b248b23d41cd836f37f8eab52027 rdf:first sg:person.0636145504.03
138 rdf:rest N0e625af632664671b86d252b1b5afeb7
139 N677e7801ab2d4262bcaf04302e6690ca rdf:first sg:person.011710475215.90
140 rdf:rest Nffe694e4c6974bec8e0bb436efbee243
141 N6a08508279d444b69a54eadfcf76d33c rdf:first sg:person.01254462007.47
142 rdf:rest Nc3a3b60aeaff472aabd35398758171da
143 N78921f08cf9f40d2a8bcf4e16bfcb64a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Graft vs Host Disease
145 rdf:type schema:DefinedTerm
146 N79d20b3ce19d498d837beb153926c2c5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
147 schema:name Bone Marrow Transplantation
148 rdf:type schema:DefinedTerm
149 N8093d0521b9c42a994d01fbe468359a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Incidence
151 rdf:type schema:DefinedTerm
152 N89e952a976234fe6b0055b29e8c7b1e9 schema:name pubmed_id
153 schema:value 14561988
154 rdf:type schema:PropertyValue
155 N997860bff4744eac9243d2e2627fb9d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Histocompatibility
157 rdf:type schema:DefinedTerm
158 Na5362ab379e449858e67333e417d2146 schema:name doi
159 schema:value 10.1038/sj.bmt.1704239
160 rdf:type schema:PropertyValue
161 Na7ecd823fb86416e8587569fd2689682 schema:name dimensions_id
162 schema:value pub.1002246124
163 rdf:type schema:PropertyValue
164 Nb3fc94d5ad134e378d3f09df4ac7bac3 schema:issueNumber 9
165 rdf:type schema:PublicationIssue
166 Nbdfdcd7db68740b8affe7c4cb3a36292 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
167 schema:name Male
168 rdf:type schema:DefinedTerm
169 Nc23b545d4784466d89e26ec70e0116f6 rdf:first sg:person.01034324775.43
170 rdf:rest N677e7801ab2d4262bcaf04302e6690ca
171 Nc3a3b60aeaff472aabd35398758171da rdf:first sg:person.01250741512.98
172 rdf:rest Ne6d1d19669cf4fe882f4670f56a22bd4
173 Nc7b034bfa431418f859e96fe68104be7 schema:name Springer Nature - SN SciGraph project
174 rdf:type schema:Organization
175 Nda8fbf829b5e41adbf2bb41b9f8b4eae schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Drug Monitoring
177 rdf:type schema:DefinedTerm
178 Ne540f593e86f4001830125e7187ce459 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Risk Factors
180 rdf:type schema:DefinedTerm
181 Ne62e98ea7e0b437287b0ba09993e5031 schema:volumeNumber 32
182 rdf:type schema:PublicationVolume
183 Ne69c0d2443e74e1683616aad41fe288d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
184 schema:name Cyclosporine
185 rdf:type schema:DefinedTerm
186 Ne6d1d19669cf4fe882f4670f56a22bd4 rdf:first sg:person.0740146060.37
187 rdf:rest N5368b248b23d41cd836f37f8eab52027
188 Nf14858ad36034db6a72d8ce6a6b63cf8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
189 schema:name Acute Disease
190 rdf:type schema:DefinedTerm
191 Nf5349a43c6984f14b0ae8025b38e421a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
192 schema:name Area Under Curve
193 rdf:type schema:DefinedTerm
194 Nffe694e4c6974bec8e0bb436efbee243 rdf:first sg:person.075614563.37
195 rdf:rest rdf:nil
196 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
197 schema:name Medical and Health Sciences
198 rdf:type schema:DefinedTerm
199 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
200 schema:name Cardiorespiratory Medicine and Haematology
201 rdf:type schema:DefinedTerm
202 sg:journal.1096890 schema:issn 0268-3369
203 1476-5365
204 schema:name Bone Marrow Transplantation
205 schema:publisher Springer Nature
206 rdf:type schema:Periodical
207 sg:person.01034324775.43 schema:affiliation grid-institutes:None
208 schema:familyName Maire
209 schema:givenName P H
210 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034324775.43
211 rdf:type schema:Person
212 sg:person.01077622701.25 schema:affiliation grid-institutes:grid.413959.3
213 schema:familyName Bertrand
214 schema:givenName Y
215 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077622701.25
216 rdf:type schema:Person
217 sg:person.011710475215.90 schema:affiliation grid-institutes:grid.42505.36
218 schema:familyName Jelliffe
219 schema:givenName R W
220 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011710475215.90
221 rdf:type schema:Person
222 sg:person.01250741512.98 schema:affiliation grid-institutes:None
223 schema:familyName Bleyzac
224 schema:givenName N
225 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01250741512.98
226 rdf:type schema:Person
227 sg:person.01254462007.47 schema:affiliation grid-institutes:grid.413959.3
228 schema:familyName Martin
229 schema:givenName P
230 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254462007.47
231 rdf:type schema:Person
232 sg:person.0636145504.03 schema:affiliation grid-institutes:grid.413959.3
233 schema:familyName Galambrun
234 schema:givenName C
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0636145504.03
236 rdf:type schema:Person
237 sg:person.0740146060.37 schema:affiliation grid-institutes:grid.413959.3
238 schema:familyName Souillet
239 schema:givenName G
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740146060.37
241 rdf:type schema:Person
242 sg:person.075614563.37 schema:affiliation grid-institutes:grid.29172.3f
243 schema:familyName Aulagner
244 schema:givenName G
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.075614563.37
246 rdf:type schema:Person
247 sg:pub.10.1038/sj.bmt.1702460 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035839342
248 https://doi.org/10.1038/sj.bmt.1702460
249 rdf:type schema:CreativeWork
250 sg:pub.10.1038/sj.bmt.1702868 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024488164
251 https://doi.org/10.1038/sj.bmt.1702868
252 rdf:type schema:CreativeWork
253 grid-institutes:None schema:alternateName ADCAPT, A Charial Hospital, Francheville, France
254 schema:name ADCAPT, A Charial Hospital, Francheville, France
255 Department of Pharmacy, Debrousse Hospital, Lyon, France
256 rdf:type schema:Organization
257 grid-institutes:grid.29172.3f schema:alternateName Faculty of Pharmacy, University H Poincaré, Nancy, France
258 schema:name Department of Pharmacy, Debrousse Hospital, Lyon, France
259 Faculty of Pharmacy, University H Poincaré, Nancy, France
260 rdf:type schema:Organization
261 grid-institutes:grid.413959.3 schema:alternateName Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France
262 Department of Pharmacy, Debrousse Hospital, Lyon, France
263 schema:name Department of Paediatric Immuno-Haematology and Bone Marrow Transplantation, Debrousse Hospital, Lyon, France
264 Department of Pharmacy, Debrousse Hospital, Lyon, France
265 rdf:type schema:Organization
266 grid-institutes:grid.42505.36 schema:alternateName Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA
267 schema:name Laboratory of Applied Pharmacokinetics, University of Southern California, School of Medicine, Los Angeles, CA, USA
268 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...